Atypical presentation of an oesophageal carcinoma with metastases to the left buttock: a case report by Smyth, Sarah et al.
Case report
Open Access
Atypical presentation of an oesophageal carcinoma with metastases
to the left buttock: a case report
Sarah Smyth
1,M a r kEO ’Donnell
2*, Susim Kumar
1, Atiq Hussain
1
and Brian Cranley
1
Address:
1Department of General Surgery, Daisy Hill Hospital, Newry BT35 8DR, Northern Ireland and
2Faculty of Life and Health Sciences,
University of Ulster, Jordanstown Campus, Shore Rd, Newtownabbey BT37 0QB, Northern Ireland
Email: SS - S1256801@qub.ac.uk; MEOD* - modonnell904@hotmail.com; SK - susimkumar@btinternet.com;
AH - atiq.hussain@southerntrust.hscni.net; BC - brian.cranley@southerntrust.hscni.net
*Corresponding author
Published: 18 May 2009 Received: 21 March 2009
Accepted: 30 April 2009 Cases Journal 2009, 2:6691 doi: 10.1186/1757-1626-2-6691
This article is available from: http://casesjournal.com/casesjournal/article/view/6691
© 2009 Smyth et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Oesophageal carcinomas represent 3% of all cancers in the UK accounting for 7650
new cases per annum. Oesophageal cancer may be associated with swallowing abnormalities,
localised mass pressure effects, lymphatic or distant metastatic spread.
Case presentation: We report a 50-year-old man who presented with a painful, enlarging, solid,
fixed lesion adjacent to the left buttock with associated dysphagia. Initial endoscopic assessment
suggested severe oesophageal inflammation while the lesion in the buttock area was presumed to be a
primary soft-tissue neoplasm. However, subsequent histological assessment confirmed a primary
oesophageal squamous carcinoma with metastatic spread to the buttock.
Conclusion: We discuss the clinical presentation, investigative modalities, and current therapeutic
guidelines associated with this rare metastasis and present other atypical oesophageal musculoskeletal
metastases. We emphasise the need to consider all aspects of patient symptomatology during the
investigation of any atypical lesion.
Introduction
Oesophageal carcinomas represent 3% of all cancers in the
UK accounting for 7650 new cases per annum [1].
Oesophageal cancer may be associated with swallowing
abnormalities, localised mass pressure effects, lymphatic
or distant metastatic spread [1].
Case presentation
A 50-year-old male Caucasian patient from Northern
Ireland presented with a 6-month history of an enlarging
firm tender swelling adjacent to his left buttock. He also
described progressive dysphagia to solids with intermit-
tent odynophagia. He had associated anorexia and weight
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other gastrointestinal symptomatology. He had no other
significant medical history but smoked 40 cigarettes a day.
There was no history of oesophageal cancer but his father
died from colon cancer aged 87. He drank alcohol
occasionally and had no previous proton pump inhibitor
usage.
On examination, he was haemodynamically stable.
Abdominal examination was unremarkable. However, he
had a suspicious 18 cm × 12 cm mass arising adjacent to
his left buttock that was tender on palpation and fixed to
the underlying left sacroiliac joint. Initial haematological
investigations demonstrated a haemoglobin level of
16.9 g/dl and a white cell count of 9.71 × 10
9/litre. Urea
and electrolytes were normal. The alkaline phosphatase
was 129 m/L and corrected calcium was 3.07 mmol/L. Both
carcinoembyronic antigen and CA 19-9 tumour marker
levels were raised at 18.7 (normal range = 0-4) and 235
(normal range = 0-37) units/ml respectively.
A plain X-ray of the pelvis demonstrated a soft tissue
density over the left sacroiliac joint without any evidence
of definite bone destruction (Figure 1). An urgent OGD
revealed marked inflammatory changes in the distal
oesophagus at 35 cm with a slightly raised mucosa
which was suspicious of an underlying malignancy.
Multiple biopsies were taken. A subsequent CLO-test was
positive for helicobacter pylori and he was commenced on
appropriate eradication therapy combined with oral
omeprazole 20 mg twice a day. A contrast-enhanced
computerised tomography of the chest, abdomen and
pelvis revealed multiple opacities in the left and right
hemithoraces suspicious of metastatic deposits (Figure 2).
The oesophagus was thick walled at the level of the
posterior mediastinum in keeping with a possible
neoplastic lesion. A large soft tissue mass was identified
arising from the posterior sacro- iliac joints (Figure 3).
There was erosion of theiliac bone into thesacro-iliac joint
with increased vascularity to the left gluteal musculature.
The differential diagnosis included an oesophageal lesion
or a primary bone tumour such as a chondrosarcoma or
osteosarcoma which had metastasised to the lung or even
a dual pathology. Although not usually associated with
such widespread metastatic disease, a solitary plasmacy-
toma was also considered. Histopathological assessments
from the oesophagus confirmed a squamous carcinoma
while an ultrasound guided biopsy from the left gluteal
mass revealed the presence of a metastatic squamous cell
carcinoma originating from the primary oesophageal
tumour.
Unfortunately with the advanced nature of the patient’s
neoplastic disease, aggressive surgical intervention was not
appropriate. Oesophageal stenting was discussed with the
patient and delayed due to a lack of complete obstructive
symptomatology. He had a 2-week course of palliative
radiotherapy (10 fraction course) to the posterior aspect of
his left pelvis with a moderate response. Unfortunately he
has developed a left foot drop which may be related to
Figure 1. There is increased soft tissue density over the left
sacro-iliac joint (white arrow). No definite bone destruction
can be visualised on this plain film X-ray.
Figure 2. This section of CT shows evidence of the multiple
opacifications in both hemithoraces in keeping with likely
metastatic deposits. There is also a good illustration of the
thick walled oesophagus at the level of the posterior
mediastinum (white arrow). This was in keeping with a
neoplastic growth of the oesophagus.
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palliative chemotherapy was planned, he was not fit to
undergo the treatment and was referred to the palliative
care team. His prognosis remains guarded.
Discussion
Oesophageal cancer occurs in 3% of the population in the
UK. In northern China and Iran, it exceeds 100 per
100,000 individuals. In America, the incidence is less than
5 per 100,000, although rates are nearly quadruple for
African Americans. The commonest site of oesophageal
cancer is the lower third of the oesophagus, followed by
the upper and middle thirds. The Scottish Audit of Gastric
and Oesophageal Cancer found that adenocarcinoma of
the oesophagus was more frequent than squamous cell
carcinoma (SCC) in a ratio of 5:4 [1]. Oesophageal cancer
is more common over the age of 55 years (median age 72).
Male sex, smoking and alcohol are risk factors for
development of SCC of the oesophagus while Barrett’s
oesophagus predisposes to adenocarcinoma [1]. Tylosis,
pernicious anaemia, achalasia and coeliac disease are all
associated with a small but increased risk of squamous cell
carcinoma [2].
Predominant symptomatology includes dyspepsia and
progressive dysphagia. Other symptoms include anorexia,
weight loss, recurrent vomiting or gastrointestinal hae-
morrhage [3]. Barium swallow or endoscopic assessment
(OGD) are first line investigative modalities while
endoscopic ultrasound and computerised tomography
permit disease staging [4]. Bronchoscopy though not
routinely advocated, is useful in revealing tracheobron-
chial invasion, especially with upper and middle third
lesions. There is evidence that PET scanning is slightly
more sensitive and specific in the detection of distant
metastasis compared to CT but not for local lymph node
detection [5].
Our patient complained of a painful enlarging buttock
mass which was assessed and biopsied radiologically.
Although oesophageal adenocarcinoma metastasising to
the gluteus minimus has been previously reported, this is
the first case of SCC metastasising to the buttock [4]. Other
atypical SCC oesophageal metastases include the iris while
metastasis to the buttock from carcinomas involving the
urinary bladder, kidneys and larynx have been documen-
ted [5]. Oesophageal adenocarcinomas have also been
reported to metastasise to rare bony areas such as the
mandible [6].
The prognosis of oesophageal cancer is poor with the
majority of patients with an unresected primary surviving
less than 6 months. A study of 838 patients with
oesophageal tumours revealed that approximately 18%
had metastases at diagnosis [7]. Five year survival is greater
than 80% for mucosal lesions, 50-80% for submucosal
infiltration, and 20% with more advanced disease [8].
Radical surgery is recommended for systemically fit
patients with localised T1 and T2 tumours. Palliative
radiotherapy can improve dysphagia in 50-85% of
patients whilst providing symptomatic relief from distant
metastases as shown in this case [9]. Laser therapy or stent
insertion are usually reserved for more severe dysphagia.
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Figure 3. CT scan of large soft tissue mass in the posterior
sacro-iliac joints (black arrow).
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